Varian Medical Systems International AG

Tweet this page
<
2016
2017
2018
2019
2020
2021
2022
>
Registration as it was on 28 May 2019
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

150,000€

Financial year: Oct 2016 - Sep 2017

Lobbyists (Full time equivalent)

0.5 Fte (2)

Lobbyists with EP accreditation

0

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    Varian Medical Systems International AG

    EU Transparency Register

    185216022477-29 First registered on 27 Jun 2016

    Goals / Remit

    Varian's mission is to focus energy on saving lives. Varian pioneered the use of high-energy X-rays for cancer treatments and developed the first linear accelerators to deliver radiotherapy. Today, Varian is the world's leading supplier of radiotherapy treatment solutions, continually improving delivery systems and advancing the field with new technologies, such as radiosurgery and proton therapy.

    Main EU files targeted

    Varian Medical Systems primarily follows EU initiatives, policies and legislative files relating to data privacy, public health and/or research and innovation (e.g., Horizon 2020), EU policy on cancer care, reimbursement and HTA, the implementation of the medical devices regulation, and medical software/AI initiatives.

    Address

    Head Office
    Varian Medical Systems International AG
    Hinterbergstrasse 14
    Cham 6330
    SWITZERLAND
  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    25%2

    Lobbyists (Full time equivalent)

    0.5

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    EU affairs issues are managed by the Senior Director responsible for government affairs based in the Netherlands and cover 20% of their working time. Additional support is provided at times by the Western Europe Government Affairs Director (based in Steinhausen, Switzerland) up to a maximum of 10% of their time.
    To clarify: 20% of Senior Director's time and 10% of Director's time. Equivalent to 30% of one FTE.

    Person in charge of EU relations

    Mr Andrew Whitman (Senior Vice President, Government Affairs and Market Access)

    Person with legal responsibility

    Mr Jean-Luc Devleeschauwer (President, Oncology Systems EMEIA & CIS)

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Companies & groups

  • Networking

    Affiliation

    Advanced Medical Technology Association (AdvaMed) - advamed.org; European Coordination Committee of the Radiological Electromedical and Healthcare IT Industry (COCIR) - cocir.org; Global Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade Association (DITTA) - globalditta.org

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Oct 2016 - Sep 2017

    Lobbying costs for closed financial year

    150,000€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    None

    Communication activities

    Horizon 2020; Europe 2020 Strategy; General Data Protection Regulation

    Other activities

    Varian Medical Systems is currently a member of the Innovative Medicines Initiative 2 (IMI2) and a member of a multi-stakeholder project co-funded under the IMI2.

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    • Date 05 Jul 2016 Location Brussels
      Subject Proton Therapy
      Cabinet Cabinet of Commissioner Corina Crețu
      Portfolio Regional Policy
      Attending
      • Mathieu Fichter (Cabinet member)
Download this datacard